Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Enanta Pharmaceuticals (ENTA) over the last 4 years, with Q2 2015 value amounting to $2000.0.

  • Enanta Pharmaceuticals' Treasury Shares changed 0.0% to $2000.0 in Q2 2015 from the same period last year, while for Jun 2015 it was $2000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $2000.0 for FY2014, which is 0.0% changed from last year.
  • Per Enanta Pharmaceuticals' latest filing, its Treasury Shares stood at $425000.0 for Q4 2025, which was down 296.8% from $408000.0 recorded in Q3 2025.
  • Over the past 5 years, Enanta Pharmaceuticals' Treasury Shares peaked at $455000.0 during Q4 2023, and registered a low of $117000.0 during Q3 2021.
  • Moreover, its 5-year median value for Treasury Shares was $418500.0 (2023), whereas its average is $339850.0.
  • Data for Enanta Pharmaceuticals' Treasury Shares shows a peak YoY increase of 0.0% (in 2013) and a maximum YoY decrease of 0.0% (in 2013) over the last 5 years.
  • Over the past 4 years, Enanta Pharmaceuticals' Treasury Shares (Quarter) stood at $2000.0 in 2012, then changed by 0.0% to $2000.0 in 2013, then changed by 0.0% to $2000.0 in 2014, then changed by 0.0% to $2000.0 in 2015.
  • Its Treasury Shares was $2000.0 in Q2 2015, compared to $2000.0 in Q1 2015 and $2000.0 in Q4 2014.